Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Doramapimod | IC50 | 30000.0 [1] | |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 1526.0 [1] | |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] | |
| 5-(4-Chlorophenyl)-N-(4-piperazin-1-ylphenyl)furan-2-carboxamide | IC50 | 30000.0 [1] | |
| 3-Methyl-N-[6-methylsulfanyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine | IC50 | 10000.0 [1] | |
MLA | "Quest Database™ Testis-specific serine/threonine-protein kinase 2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 13 Dec. 2025, https://www.aatbio.com/data-sets/testis-specific-serine-threonine-protein-kinase-2-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 13). Quest Database™ Testis-specific serine/threonine-protein kinase 2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/testis-specific-serine-threonine-protein-kinase-2-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |